AZ unveils detailed data from THALES trial
The results show a 17% cut in the risk of subsequent stroke in patients taking Brilinta and aspirin
Read More
Tag: aspiring
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
